en nl fr


Not yet

Create your
account in
order to
access your
membership space
67. Amendment of document ‘AT-08 - cross-contamination’

Document AT-08 has been updated following the communication of 1 new multiplication factor for the premix Pigfen 40 mg/g.


Companies, placing medicated premixtures and/or additives on the market, and having the results of the relative wall adhesion tests, may communicate them to OVOCOM by email (info@ovocom.be). Companies must also ensure that results, previously communicated, are updated. After evaluation, they will be incorporated in document ‘AT-08 – Cross-Contamination’.


The changes in this document are highlighted in gray.

20 Oct 2017


31, rue de l'Hôpital

1000 Brussels

Register of legal entities Brussels

Tel. +32 (0) 2 514 01 86

Fax +32 (0) 2 514 05 29

BE 0474.646.635


Privacy policy  I  Disclaimer  I  @ Ovocom 2020